Outcomes in risk-stratified patients with smoldering multiple myeloma: a retrospective analysis of real-world data from the Czech Registry of Monoclonal Gammopathies

被引：0
|
作者：
Sandecka, Viera [1 ]
Popkova, Tereza [2 ]
Stork, Martin [1 ]
Maisnar, Vladimir [3 ]
Minarik, Jiri [4 ]
Jungova, Alexandra [5 ]
Pavlicek, Petr [6 ]
Stejskal, Lukas [7 ]
Pospisilova, Lenka [8 ]
Heindorfer, Adriana [9 ]
Obernauerova, Jarmila [10 ]
Gregora, Evzen [11 ]
Sykora, Michal [12 ]
Ullrychova, Jana [13 ]
Wrobel, Marek [14 ]
Kessler, Petr [15 ]
Lukesova, Hana [16 ]
Jelinek, Tomas [2 ]
Kunovszki, Peter [17 ]
Bathija, Sacheeta [17 ]
Otero, Blanca Gros [18 ]
Wilbertz, Sabine [19 ]
Cai, Qian [20 ]
Lam, Annette [21 ]
Spicka, Ivan [22 ]
机构：
[1] Univ Hosp Brno, Brno, Czech Republic
[2] Univ Hosp Ostrava, Ostrava, Czech Republic
[3] Univ Hosp Hradec Kralove, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic
[4] Univ Hosp Olomouc, Olomouc, Czech Republic
[5] Univ Hosp Plzen, Plzen, Czech Republic
[6] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic
[7] Silesian Hosp Opava, Opava, Czech Republic
[8] Inst Biostat & Analyses Ltd, Brno, Czech Republic
[9] Liberec Reg Hosp, Liberec, Czech Republic
[10] Reg Hosp Mlada Boleslav, Mlada Boleslav, Czech Republic
[11] Motol Univ Hosp, Prague, Czech Republic
[12] Hosp Ceske Budejovice, Ceske Budejovice, Czech Republic
[13] Masaryk Hosp Usti Nad Labem, KZ, Usti Nad Labem, Czech Republic
[14] Hosp Novy Jicin, Novy Jicin, Czech Republic
[15] Hosp Pelhrimov, Pelhrimov, Czech Republic
[16] Thomayer Univ Hosp, Prague, Czech Republic
[17] Janssen Global Serv, Prague, Czech Republic
[18] Jan Cil Spain, Madrid, Spain
[19] Janssen Cilag GmbH, Neuss, Germany
[20] Janssen R&D US, Raritan, NJ USA
[21] Janssen Inc Canada, Toronto, ON, Canada
[22] Charles Univ Prague, Dept Hematol, Prague, Czech Republic
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-177
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [31] Real-World Retrospective Study of 46 Patients with Macrofocal Multiple Myeloma (MFMM)
    Yan, Wenqiang
    Fan, Huishou
    Xu, Jingyu
    Liu, Jiahui
    Du, Chenxing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Qiu, Lugui
    An, Gang
    [J]. BLOOD, 2021, 138 : 3765 - +
  • [32] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [33] Ixazomib plus Lenalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Pooled Analysis from the INSIGHT MM Observational Study and the Czech Registry of Monoclonal Gammopathies
    Cook, G.
    Hajek, R.
    Terpos, E.
    Lee, H. C.
    Chari, A.
    Costello, C. L.
    Puig, N.
    Leleu, X.
    Berdeja, J. G.
    Davies, F. E.
    Weisel, K. C.
    Usmani, S. Z.
    Hungria, V. T. M.
    Boccadoro, M.
    Rifkin, R. M.
    Zonder, J. A.
    Brozova, L.
    Barinova, M.
    Ren, K.
    Cacioppo, R.
    Skacel, T.
    Stull, D. M.
    Maisnar, V.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 16 - 17
  • [34] Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
    Remes, Kari
    Anttila, Pekka
    Silvennoinen, Raija
    Putkonen, Mervi
    Ollikainen, Hanna
    Terava, Venla
    Sinisalo, Marjatta
    Kananen, Kristiina
    Schain, Frida
    Castren-Kortegangas, Paivi
    Jarvinee, Tiina M.
    Pisini, Marta
    Wahl, Felix
    Dixon, Tricia
    Leval, Amy
    [J]. PLOS ONE, 2018, 13 (12):
  • [35] Real-world clinical outcomes and treatment patterns among patients with triple-class exposed multiple myeloma: an analysis using the Connect® multiple myeloma disease registry
    Lee, Hans
    Ailawadhi, Sikander
    Dhanda, Devender
    Patwardhan, Pallavi
    Yu, Edward
    Liu, Liang
    Rifkin, Robert
    Terebelo, Howard
    Abonour, Rafat
    Narang, Mohit
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James
    Durie, Brian
    Jagannath, Sundar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S193 - S194
  • [36] Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry
    Ballas, Leslie
    Ailawadhi, Sikander
    Narang, Mohit
    Gasparetto, Cristina J.
    Lee, Hans C.
    Hardin, James W.
    Durie, Brian G. M.
    Toomey, Kathleen
    Omel, James
    Wagner, Lynne I.
    Abonour, Rafat
    Terebelo, Howard R.
    Joshi, Prashant
    Yu, Edward
    Liu, Liang
    Rifkin, Robert M.
    Jagannath, Sundar
    [J]. PRACTICAL RADIATION ONCOLOGY, 2024, 14 (02) : e141 - e149
  • [37] REAL-WORLD EFFECTIVENESS OF MONOCLONAL ANTIBODIES FOR PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW
    Lai, J. H.
    Kenawy, A. S.
    Aiyeolemi, A. A.
    Russo, A. J.
    Sohn, T. J.
    Chen, S.
    Rascati, K. L.
    Avancena, A. L., V
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S37 - S37
  • [38] Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data
    van den Puttelaar, Rosita
    Meester, Reinier G. S.
    Peterse, Elisabeth F. P.
    Zauber, Ann G.
    Zheng, Jiayin
    Hayes, Richard B.
    Su, Yu-Ru
    Lee, Jeffrey K.
    Thomas, Minta
    Sakoda, Lori C.
    Li, Yi
    Corley, Douglas A.
    Peters, Ulrike
    Hsu, Li
    Lansdorp-Vogelaar, Iris
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3415 - 3423.e29
  • [39] Cardiac Events in Real-World Multiple Myeloma Patients Treated with Carfilzomib: A Retrospective Claims Database Analysis
    Chari, Ajai
    Aggarwal, Sanjay K.
    Mezzi, Khalid
    Wang, Kenneth
    Kim, Christopher
    Zhu, Shao
    Braunlin, Megan
    Werther, Winifred
    Mikhael, Joseph
    [J]. BLOOD, 2016, 128 (22)
  • [40] Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum
    Shimura, Yuji
    Shibayama, Hirohiko
    Nakaya, Aya
    Yamamura, Ryosuke
    Imada, Kazunori
    Kaneko, Hitomi
    Hanamoto, Hitoshi
    Fuchida, Shin-ichi
    Tanaka, Hirokazu
    Kosugi, Satoru
    Kiyota, Miki
    Matsui, Toshimitsu
    Kanda, Junya
    Iida, Masato
    Matsuda, Mitsuhiro
    Uoshima, Nobuhiko
    Shibano, Masaru
    Karasuno, Takahiro
    Hamada, Tsuneyoshi
    Ohta, Kensuke
    Ito, Tomoki
    Yagi, Hideo
    Yoshihara, Satoshi
    Shimazaki, Chihiro
    Nomura, Shosaku
    Hino, Masayuki
    Takaori-Kondo, Akifumi
    Matsumura, Itaru
    Kanakura, Yuzuru
    Kuroda, Junya
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (05) : 609 - 617
12345